1. (a) The chief law enforcement officer of a law enforcement agency seeking to establish a pharmaceutical drug take-back program in conjunction with a government entity or private entity, may request a waiver of specific rules outlined in this chapter in accordance with (c) below.

2. (b) The chief law enforcement officer requesting a waiver shall submit the information set forth in (c) in writing to the department at:

   Department of Justice

   Criminal Bureau

   33 Capitol Street

   Concord, NH 03301

3. (c) The waiver request shall set forth the following information:

   1. (1) A description of the pharmaceutical drug take-back program to which the waiver request relates;
   2. (2) A reference to the specific section of the rules for which a waiver is being sought;
   3. (3) A full and detailed explanation of why a waiver is necessary;
   4. (4) Whether the waiver is needed for a limited duration and, if so, an estimate of when the waiver will no longer be needed;
   5. (5) A full explanation with supporting data of the alternatives, if any, proposed to be implemented or used in lieu of the rule requirements; and

   6. (6) A full explanation of how the waiver, including any proposed alternatives:

      1. a. Would be consistent with the intent of RSA 318, RSA 318-B, and RSA 318-E; and
      2. b. Would adequately protect human health and the environment and prevent the illegal diversion of collected pharmaceutical drugs.

Source. #10177, eff 8-23-12; ss by #13551, eff 2-2-23